Entera Bio Ltd.
ENTX
$1.96
-$0.02-1.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.82% | -27.27% | -18.20% | -26.99% | 7.74% |
| Total Depreciation and Amortization | -36.36% | -38.46% | -15.38% | -21.43% | -26.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.46% | 31.87% | 73.08% | 134.17% | 26.44% |
| Change in Net Operating Assets | 136.41% | 277.32% | 130.32% | -117.19% | -26.95% |
| Cash from Operations | -22.17% | 24.60% | 43.94% | -41.25% | 14.37% |
| Capital Expenditure | -- | -- | 40.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 40.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.06% | 44,976.67% | -46.45% | -- | 24,600.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -294.74% | -- | 44.31% | -- | -- |
| Cash from Financing | -104.19% | 44,356.67% | -46.66% | -- | 24,220.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,337.82% | 750.93% | -48.75% | -40.39% | 92.35% |